November; Goodrich Aerostructures, which laid off 112 workers; and La Jolla Pharmaceuticals, which is winding down its business and has filed a notice to lay off all 94 employees.
—Luke laid out a comprehensive survey of available cash at 23 publicly traded life sciences companies. He found six that have less than $50 million.
—The independent accountants at ethanol maker Verenium (NASDAQ: VRNM), a biofuels startup based in San Diego and Cambridge, MA, added a statement to a regulatory filing last week that raises questions about Verenium’s ability to continue as a going concern. Verenium CEO Carlos Riva maintained the company is not in a cash crisis.
—Anadys Pharmaceuticals’ CEO Steve Worland told Luke he’s looking for a partnership with a major pharma after getting promising results earlier this year for the drug Anadys is developing to treat hepatitis C. The biotech’s strategy calls for developing ANA-598, a non-nucleoside polymerase inhibitor, as a key ingredient in a drug “cocktail” to overwhelm the virus.
—A San Diego federal judge dismissed a patent infringement lawsuit that Irvine, CA-based Broadcom filed in October against Qualcomm, the San Diego wireless technology giant. The dismissal was good news for Qualcomm, but a Broadcom spokesman says the Irvine chipmaker plans to address the legal deficiencies identified in its case and refile the suit.
—After rebuffing a buyout offer from San Diego’s Sequenom (NASDAQ: [[ticker:SQNM]]), the board of Exact Sciences has replaced the CEO and CFO at the Marlborough, MA, medical diagnostics company.
—For the first time in March Madness history, Qualcomm’s MediaFLO is broadcasting all 63 games of the NCAA men’s basketball tournament to AT&T customers who own a mobile TV-enabled wireless device. MediaFLO also is broadcasting a limited number of games for Verizon customers.